<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126097">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01947374</url>
  </required_header>
  <id_info>
    <org_study_id>017-05-INR</org_study_id>
    <nct_id>NCT01947374</nct_id>
  </id_info>
  <brief_title>Arthroscopic Autologous Chondrocyte Implantation Versus Microfractures</brief_title>
  <official_title>Matrix-encapsulated Arthroscopic Autologous Chondrocyte Implantation Versus Microfractures for Articular Cartilage Regeneration. Randomised Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Rehabilitacion</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Council of Science and Technology, Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Nacional de Rehabilitacion</source>
  <oversight_info>
    <authority>Mexico: Federal Commission for Sanitary Risks Protection</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a phase III, randomised controlled trial of matrix-encapsulated chondrocyte
      implantation procedure compared to the microfracture procedure in the repair of symptomatic
      cartilage lesions of the knee.  Eligible patients were asked for informed consent
      preoperatively and randomised for chondrocyte implantation of microfractures.  Those
      patients allocated to the chondrocyte implantation group will be harvested at time of first
      arthroscopic procedure and concurrent lesions were treated, as meniscus repair, ligament
      reconstruction, or malalignment corrected.  The patients allocated to microfracture will be
      treated at the time of the only arthroscopic procedure. Both groups will have the same
      rehabilitation program. Prospective clinical, radiographic and magnetic resonance imaging
      will be performed as main outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>MRI T2 Mapping</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Special magnetic resonance imaging technique for measurement of collagen and water content, expressed in milliseconds.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical evaluation</measure>
    <time_frame>0, 10, 30 days; 3, 6, 9 ,12, 24, 36 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Clinical assessment with validated knee scores, and adverse effects register are taken.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Tear; Knee, Cartilage, Articular</condition>
  <arm_group>
    <arm_group_label>Chondrocyte implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>From a previous biopsy, articular cartilage matrix is digested and chondrocytes are cultured in 2 passages until implants with at least 6,000,000 cells are constructed. These constructus of 8 mm in diameter are implanted arthroscopically by means of biodegradable anchor (MINILOK QUICKANCHOR TM from DePuy-Mitek ) located at the defect and tied securely.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microfractures</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subchondral bone perforations that allow a clot to be formed, and subsequent scar at the cartilage defect area.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Matrix encapsulated chondrocyte implantation</intervention_name>
    <description>Each implant contains 6,000,000 autologous chondrocytes.</description>
    <arm_group_label>Chondrocyte implantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microfracture awl</intervention_name>
    <description>Is an awl that allow perforation of the subchondral bone.</description>
    <arm_group_label>Microfractures</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with symptomatic single chondral lesions of the knee from 1 to 4 cm2.

          -  Signed patient informed consent.

          -  Agree to adhere to rehabilitation protocol.

        Exclusion Criteria:

          -  Inflammatory arthritis, septic arthritis, gout, pseudogout, Paget's disease,
             ochronosis, acromegaly, hemochromatosis, tumors, collagen mutations.

          -  Total meniscectomy

          -  Malalignment

          -  Evidence of osteoarthritis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clemente Ibarra, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>INR</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luis G Ibarra, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>INR</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Enrique Villalobos, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>INR</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aldo F Izaguirre, M.D. M.Sc.</last_name>
    <role>Study Director</role>
    <affiliation>INR</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aldo F Izaguirre, M.D.</last_name>
    <phone>525559991000</phone>
    <phone_ext>19607</phone_ext>
    <email>aldoizag@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Enrique Villalobos, M.D.</last_name>
    <phone>525559991000</phone>
    <phone_ext>19607</phone_ext>
    <email>villalobosenrique@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Institute of Rehabilitation</name>
      <address>
        <city>Mexico City</city>
        <zip>14389</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aldo F Izaguirre, M.D.</last_name>
      <phone>525559991000</phone>
      <phone_ext>1960</phone_ext>
      <email>aldoizag@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Clemente Ibarra, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Enrique Villalobos, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aldo Izaguirre, M.D. M.Sc.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <link>
    <url>http://www.inr.gob.mx</url>
    <description>Official site of the INR</description>
  </link>
  <reference>
    <citation>Masri M, Lombardero G, Velasquillo C, Martínez V, Neri R, Villegas H, Ibarra C. Matrix-encapsulation cell-seeding technique to prevent cell detachment during arthroscopic implantation of matrix-induced autologous chondrocytes. Arthroscopy. 2007 Aug;23(8):877-83.</citation>
    <PMID>17681210</PMID>
  </reference>
  <reference>
    <citation>Ibarra-Ponce de León JC, Velasquillo-Martínez MC, Izaguirre A, Villalobos-Córdova E, Masri M, Ibarra-Ibarra LG. [Cartilage repair: cell-based techniques]. Acta Ortop Mex. 2009 Jan-Feb;23(1):38-44. Review. Spanish.</citation>
    <PMID>19462773</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 17, 2013</lastchanged_date>
  <firstreceived_date>February 4, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Rehabilitacion</investigator_affiliation>
    <investigator_full_name>Aldo Izaguirre</investigator_full_name>
    <investigator_title>Dr./Study Director</investigator_title>
  </responsible_party>
  <keyword>Cartilage</keyword>
  <keyword>Articular</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
